Efficacy and safety of selamectin against <font color="blue">fleas_1</font> <font color="blue">and_1</font> <font color="blue">heartworms_1</font> <font color="blue">in_1</font> <font color="blue">dogs_3</font> <font color="blue">and_3</font> <font color="blue">cats_3</font> <font color="blue">presented_2</font> <font color="blue">as_2</font> <font color="blue">veterinary_3</font> <font color="blue">patients_3</font> <font color="blue">in_3</font> <font color="blue">North_3</font> <font color="blue">America_3</font> <font color="blue">._3</font> 
<br>
<br> A series of randomized , controlled , masked field studies was conducted to assess the efficacy and safety of selamectin in the treatment of <font color="blue">flea_1</font> <font color="blue">infestations_1</font> <font color="blue">on_1</font> <font color="blue">dogs_2</font> <font color="blue">and_2</font> <font color="blue">cats_2</font> <font color="blue">,_2</font> and in the prevention of <font color="blue">heartworm_1</font> <font color="blue">infection_1</font> <font color="blue">in_1</font> <font color="blue">dogs_2</font> <font color="blue">._2</font> In addition , observations were made on the beneficial effect of selamectin treatment on <font color="blue">dogs_1</font> <font color="blue">and_1</font> <font color="blue">cats_1</font> <font color="blue">showing_1</font> <font color="blue">signs_1</font> <font color="blue">of_1</font> <font color="blue">flea_2</font> <font color="blue">allergy_2</font> <font color="blue">dermatitis_2</font> <font color="blue">(_2</font> <font color="blue">FAD_2</font> <font color="blue">)_2</font> <font color="blue">._2</font> In all studies selamectin was applied topically , once per month , in unit doses providing a minimum dosage of 6mgkg(-1 ) . <font color="blue">Dogs_4</font> <font color="blue">and_4</font> <font color="blue">cats_4</font> <font color="blue">with_3</font> <font color="blue">naturally_3</font> <font color="blue">occurring_3</font> <font color="blue">flea_3</font> <font color="blue">infestations_3</font> <font color="blue">,_3</font> <font color="blue">some_3</font> <font color="blue">of_3</font> <font color="blue">which_3</font> <font color="blue">also_3</font> <font color="blue">had_3</font> <font color="blue">signs_3</font> <font color="blue">associated_3</font> <font color="blue">with_3</font> <font color="blue">FAD_3</font> <font color="blue">,_3</font> <font color="blue">were_1</font> <font color="blue">assigned_1</font> <font color="blue">randomly_1</font> <font color="blue">to_1</font> <font color="blue">receive_1</font> <font color="blue">three_1</font> <font color="blue">months_1</font> <font color="blue">of_1</font> <font color="blue">topical_1</font> <font color="blue">treatment_1</font> <font color="blue">with_1</font> <font color="blue">selamectin_1</font> <font color="blue">(_1</font> <font color="blue">220_2</font> <font color="blue">dogs_2</font> <font color="blue">,_2</font> <font color="blue">189_2</font> <font color="blue">cats_2</font> <font color="blue">)_2</font> or a positive - control product ( dogs : fenthion , n=81 ; cats : pyrethrins , n=66 ) . Selamectin was administered on days 0 , 30 , and 60 . Day 0 was defined as the day that the animal first received treatment . Flea burdens were assessed by flea comb counts and clinical evaluations of FAD were performed before treatment , and on days 14 , 30 , 60 , and 90 . On days 30 , 60 , and 90 , mean flea counts in selamectin - treated dogs were reduced by 92.1 , 99.0 , and 99.8% , and mean flea counts in fenthion - treated dogs were reduced by 81.5 , 86.8 , and 86.1% , respectively , compared with day 0 counts . Also , on days 30 , 60 , and 90 , mean flea counts in selamectin - treated cats were reduced by 92.5 , 98.3 , and 99.3% , and mean flea counts in pyrethrin - treated cats were reduced by 66.4 , 73.9 , and 81.3% , respectively , compared with day 0 counts . Selamectin also was beneficial in alleviating signs in <font color="blue">dogs_1</font> <font color="blue">and_1</font> <font color="blue">cats_1</font> <font color="blue">diagnosed_1</font> <font color="blue">clinically_1</font> <font color="blue">with_1</font> <font color="blue">FAD_1</font> <font color="blue">._1</font> A total of <font color="blue">397_2</font> <font color="blue">dogs_2</font> <font color="blue">free_1</font> <font color="blue">of_1</font> <font color="blue">adult_1</font> <font color="blue">heartworm_1</font> <font color="blue">infection_1</font> <font color="blue">from_1</font> <font color="blue">four_1</font> <font color="blue">heartworm_1</font> <font color="blue">-_1</font> <font color="blue">endemic_1</font> <font color="blue">areas_1</font> <font color="blue">of_1</font> <font color="blue">the_1</font> <font color="blue">USA_1</font> were allocated randomly to six months of treatment with selamectin ( n=298 ) or ivermectin ( n=99 ) . Selamectin achieved a heartworm prevention rate of 100% , with all dogs testing negative for microfilariae and adult heartworm antigen on days 180 and 300 . Selamectin was administered to a total of <font color="blue">673_1</font> <font color="blue">dogs_1</font> <font color="blue">and_1</font> <font color="blue">347_1</font> <font color="blue">cats_1</font> having an age range of 6 weeks to 19 years ( 3954 doses ) . The <font color="blue">animals_1</font> <font color="blue">included_1</font> <font color="blue">19_2</font> <font color="blue">purebred_2</font> <font color="blue">or_2</font> <font color="blue">crossbred_2</font> <font color="blue">Collies_2</font> <font color="blue">(_2</font> <font color="blue">Bearded_2</font> <font color="blue">,_2</font> <font color="blue">Border_2</font> <font color="blue">,_2</font> <font color="blue">and_2</font> <font color="blue">unspecified_2</font> <font color="blue">)_2</font> <font color="blue">._1</font> There were no serious adverse events . Results of these studies indicated that selamectin was highly effective in the control of flea infestations in <font color="blue">dogs_1</font> <font color="blue">and_1</font> <font color="blue">cats_1</font> without the need for simultaneous treatment of the environment or of in - contact animals and also was beneficial in alleviating signs associated with FAD . Selamectin also was 100% effective in preventing the development of canine heartworms and was safe for topical use in <font color="blue">dogs_2</font> <font color="blue">and_2</font> <font color="blue">cats_2</font> <font color="blue">._2</font>